Patents by Inventor Bruce A. Pfeffer

Bruce A. Pfeffer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120065228
    Abstract: A composition for treating, controlling, reducing, or ameliorating inflammatory pain comprises a dissociated glucocorticoid receptor agonist (“DIGRA”), a prodrug thereof, a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable ester thereof. The composition can comprise an additional anti-inflammatory agent and can be formulated for topical application, injection, or implantation. It may be used in a method of managing ocular inflammation and/or pain such that it has lower risk of eliciting increased intraocular pressure seen with glucocorticoids.
    Type: Application
    Filed: September 26, 2011
    Publication date: March 15, 2012
    Inventors: Jinzhong Zhang, Keith W. Ward, Timothy L. Comstock, Dale W. Usner, Bruce A. Pfeffer, Mercedes Salvador-Silva, Charu A. DeWitt, Francisco J. Lopez, Claudio Bucolo
  • Publication number: 20110077270
    Abstract: A composition for treating or controlling an ocular disease or condition comprises a dissociated glucocorticoid receptor agonist (“DIGRA”), which disease or condition has an etiology, or results, in inflammation. The composition can optionally include an anti-inflammatory agent, an anti-infective agent, or both. The composition can be formulated for topical application, injection, or implantation in an affected eye to treat or control the ocular inflammatory disease or condition.
    Type: Application
    Filed: March 26, 2010
    Publication date: March 31, 2011
    Inventors: Bruce A. Pfeffer, Mercedes Salvador-Silva, Charu A. DeWitt, Keith W. Ward, Francisco J. Lopez
  • Publication number: 20100104551
    Abstract: A composition of a long-acting enzyme comprises the enzyme in a formulation comprising a buffer and an additive selected from the group consisting of tranexamic acid, ?-aminocaproic acid, and analogs of L-lysine other than tranexamic acid and ?-aminocaproic acid, combinations thereof, and mixtures thereof. The composition can further comprise another additive selected from the group consisting of L-lysine, L-arginine, L-ornithine (or its pharmaceutically acceptable salts; e.g., L-ornithine hydrochloride), ?-aminobutyric acid, 5-aminovaleric acid, 7-aminoheptanoic acid, glycylglycine, triglycine, N-?-acetyl-L-arginine, betaine, sarcosine, gelatin, HSA, streptokinase, tPA, uPA, non-ionic surfactants, glycerin, D-sorbitol, combinations thereof, and mixtures thereof. A method for prolonging the activity of an autodegradable enzyme comprises storing the enzyme after manufacture at a low pH, and reconstituting the acidified enzyme before use with a solution containing at least one of such additives.
    Type: Application
    Filed: October 22, 2009
    Publication date: April 29, 2010
    Applicant: Talecris Biotherapeutics, Inc.
    Inventors: Dharmendra M. Jani, Kai Kwok, Gregory L. McIntire, Bruce A. Pfeffer, Afshin Shafiee, Ruiwen Shi, Srini Venkatesh, Hongna Wang, Yan Huang, Stephen R. Davio